Home ►
Additional frequently asked questions about clinical trials and device coverage
Last Modified: 7/26/2024
Location: FL, PR, USVI
Business: Part A, Part B
Q: I have an “investigational drug” that is IND approved. Do I need to submit any information to First Coast for approval?
Q: What is a humanitarian use device (HUD)?
A: An HUD is a medical device the FDA has approved for clinical investigation in accordance with its approved indication (s) for a different indication.
Q: How do I get First Coast to approve a HUD?
A: You do not need to submit an application for approval to First Coast for a HUD. Simply file the claims as appropriate keeping the medical documentation on file.
Q: What is a humanitarian device exemption (HDE)?
A: The HDE is the term used when filing an application with the FDA for a device exempt from the premarket approval application effectiveness requirements.
Q: Do I submit non-significant and significant risk devices to First Coast for approval?
Q: What does the phrase “compassionate use” mean?
A: The compassionate use provision allows access for patients whom the treating physician believes the device may provide a benefit in treating their disease, but do not meet the clinical trial requirements.
Q: How do I get First Coast to approve compassionate use?
A: First Coast does not approve compassionate use for a single patient or small group. The FDA must approve before compassionate use occurs.
Q: Do I need to get approval from First Coast for transcatheter aortic valve replacement (TAVR)?
A: No. TAVR, also known as transcatheter aortic valve implantation, became nationally covered in 2012. Therefore, the billing and processing of TAVR claims is different from IDEs that require First Coast or CMS approval prior to billing for associated routine costs. Please follow our
Transcatheter aortic valve replacement claim submission guidelines.
Q: Do I need to get approval from First Coast for transcatheter mitral valve repair (TMVR)?
A: No.
TMVR is a procedure used to treat mitral regurgitation which is the most common type of heart valve insuffiency in the country. CMS issued NCD
20.33 , which allows for coverage of TMVR under coverage with evidence development with certain conditions. In addition, the
TMVR website reflects the Medicare approved registry and Medicare approved clinical trial which have been reviewed and determined to meet the requirements of coverage. Billing and coding guidelines can be found in the CMS
Pub. 100-04, Medicare Claims Processing Manual, Chapter 32, Section 340 .
Q: Where can I find information about Medicare coverage related to IDEs in Medicare Advantage plans?
Q: How are clinical studies approved under coverage with evidence development (CED)?
A: In NCDs requiring CED, Medicare covers items and services in CMS-approved CED studies. Approved CED studies are posted on the CMS
Coverage with Evidence Development webpage. Please reference the billing instructions for each NCD.
Q: Is there reimbursement for sham procedures during clinical trials?
A: While the items and services furnished as placebo controls may not be considered reasonable and necessary under section 1862 (a)(1)(A) of the statute because they have no health benefit, these items and services can be necessary to conduct a scientifically valid clinical study. As such, these services can be covered under section 1862(a)(1)(E) when furnished in the context of a clinical study where coverage is necessary to preserve the scientific integrity of the study. For more information, please see the CMS
Coverage with Evidence Development webpage.
Q: Am I required to report the NCT number on my IDE/clinical trial claim?
A: Yes. It is mandatory to report a clinical trial number (NCT), on claims for items/services provided in clinical trials/studies/registries, or under coverage with evidence development (CED). Claims submitted without the 8-digit clinical trial number will be returned as unprocessable. The associated IDE number must still be reported on the claim form as well as the mandatory 8-digit NCT number.
Q: If I am billing for a Category III (“CAT III”) device along with routine costs associated with the device that is an exemption and only approved by the FDA when used as part of a clinical trial, do I follow the reporting guidelines for Investigational Device Exemption (IDE)Studies?
Q: Is it my responsibility to determine if the services I am billing are an exemption and can only be billed within a clinical trial?
A: Yes. There are many devices and/or services that are covered only if performed during a clinical trial. It is the sponsor’s duty to provide this information to the institution billing for the services. They should also ensure the services billed are within the effective start date of a clinical trial. All of this and more can be found on
clinicaltrials.gov .
Q: Do I need to send First Coast an IDE submission for Carotid Artery Stent (CAS) or Non- Carotid Artery Stent studies?
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.